Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+11.28%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$91.9B
AUM Growth
+$1.19B
(+1.3%)
Cap. Flow
-$6.54B
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
16.39%
Holding
2,048
New
87
Increased
858
Reduced
644
Closed
75
Top Buys
| 1 |
Bentley Systems
BSY
|
$186M |
| 2 |
Rockwell Automation
ROK
|
$184M |
| 3 |
Dynatrace
DT
|
$161M |
| 4 |
Ingersoll Rand
IR
|
$147M |
| 5 |
UiPath
PATH
|
$143M |
Top Sells
| 1 |
Synopsys
SNPS
|
$601M |
| 2 |
NVIDIA
NVDA
|
$419M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$252M |
| 4 |
American Water Works
AWK
|
$231M |
| 5 |
KLA
KLAC
|
$218M |
Sector Composition
| 1 | Technology | 30.75% |
| 2 | Industrials | 18.36% |
| 3 | Healthcare | 14.73% |
| 4 | Consumer Discretionary | 7.77% |
| 5 | Utilities | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Interactive Brokers
IBKR
$27.2B
| $52.5M | 0.06% |
1,881,412
-469,096
| -20% | -$13.1M |
|
302
Rhythm Pharmaceuticals
RYTM
$6.63B
| $52.5M | 0.06% |
1,211,679
+47,718
| +4% | +$2.07M |
|
303
Citigroup
C
$176B
| $52.4M | 0.06% |
827,980
-29,193
| -3% | -$1.85M |
|
304
Royal Bank of Canada
RY
$204B
| $52.3M | 0.06% |
516,289
-3,781
| -0.7% | -$383K |
|
305
T-Mobile US
TMUS
$273B
| $52.3M | 0.06% |
320,397
-23,637
| -7% | -$3.86M |
|
306
Nextracker
NXT
$10.3B
| $52.2M | 0.06% |
925,333
-19,689
| -2% | -$1.11M |
|
307
Electronic Arts
EA
$42B
| $52.1M | 0.06% |
392,878
+15,705
| +4% | +$2.08M |
|
308
UFP Industries
UFPI
$6.01B
| $51.9M | 0.06% |
421,595
-347,333
| -45% | -$42.7M |
|
309
Planet Fitness
PLNT
$8.75B
| $51M | 0.06% |
814,472
+93,057
| +13% | +$5.83M |
|
310
TG Therapeutics
TGTX
$5.14B
| $50.6M | 0.06% |
3,327,214
-58,031
| -2% | -$883K |
|
311
Interparfums
IPAR
$3.65B
| $50.3M | 0.05% |
357,960
+27,783
| +8% | +$3.9M |
|
312
Exelixis
EXEL
$10.1B
| $48.9M | 0.05% |
2,053,333
-171,576
| -8% | -$4.08M |
|
313
Ultragenyx Pharmaceutical
RARE
$3.04B
| $48.5M | 0.05% |
1,036,374
+13,238
| +1% | +$619K |
|
314
Madrigal Pharmaceuticals
MDGL
$10.1B
| $48.4M | 0.05% |
184,163
+12,998
| +8% | +$3.42M |
|
315
PVH
PVH
$4.07B
| $48.3M | 0.05% |
343,963
+160,878
| +88% | +$22.6M |
|
316
Dayforce
DAY
$10.9B
| $48.1M | 0.05% |
727,128
+50,363
| +7% | +$3.33M |
|
317
Toll Brothers
TOL
$14.3B
| $47.9M | 0.05% |
370,195
-135,170
| -27% | -$17.5M |
|
318
Toronto Dominion Bank
TD
$128B
| $47.8M | 0.05% |
787,232
-25,391
| -3% | -$1.54M |
|
319
Iovance Biotherapeutics
IOVA
$861M
| $47.5M | 0.05% |
3,250,554
-2,012,755
| -38% | -$29.4M |
|
320
SBA Communications
SBAC
$20.5B
| $46.7M | 0.05% |
215,392
+28,167
| +15% | +$6.1M |
|
321
GitLab
GTLB
$7.99B
| $46.6M | 0.05% |
798,292
+788,126
| +7,753% | +$46M |
|
322
NVR
NVR
$23.6B
| $46.4M | 0.05% |
5,735
+1,953
| +52% | +$15.8M |
|
323
Schlumberger
SLB
$53.4B
| $46.3M | 0.05% |
845,559
+16,472
| +2% | +$903K |
|
324
Mondelez International
MDLZ
$80.1B
| $45.9M | 0.05% |
656,401
-33,730
| -5% | -$2.36M |
|
325
Immunocore
IMCR
$1.85B
| $45.9M | 0.05% |
706,607
-103,000
| -13% | -$6.7M |
|